Loci associated with N-glycosylation of human IgG are not associated with rheumatoid arthritis: A Mendelian randomisation study

Annals of the Rheumatic Diseases

Volumn 75, Issue 1, 2016, Pages 317-320

  Yarwood, Annie ^a   Viatte, Sebastien ^a   Okada, Yukinori ^b,c,d,e   Plenge, Robert ^f   Yamamoto, Kazuhiko ^e,g   Barton, Anne ^a,h   Symmons, Deborah ^a,h   Raychaudhuri, Soumya ^a,c   Klareskog, Lars ⁱ   Gregersen, Peter ^j   Worthington, Jane ^a,h   Eyre, Steve ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^e RIKEN Center for Integrative Medical Sciences   (Japan)

^f MERCK RESEARCH LABORATORIES   (United States)

^g UNIVERSITY OF TOKYO   (Japan)

^h MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

ⁱ KAROLINSKA INSTITUTE   (Sweden)

^j FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; IMMUNOGLOBULIN G; TUMOR NECROSIS FACTOR INHIBITOR; BIOLOGICAL PRODUCT; GLYCOSYLATED IGG; TUMOR NECROSIS FACTOR;

ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC BACKGROUND; GLYCOSYLATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; ANTAGONISTS AND INHIBITORS; ARTHRITIS, RHEUMATOID; CASE CONTROL STUDY; GENE LOCUS; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; MENDELIAN RANDOMIZATION ANALYSIS; META ANALYSIS; PROCEDURES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

ARTHRITIS, RHEUMATOID; BIOLOGICAL PRODUCTS; CASE-CONTROL STUDIES; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GLYCOSYLATION; HUMANS; IMMUNOGLOBULIN G; LINKAGE DISEQUILIBRIUM; MENDELIAN RANDOMIZATION ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84954395316     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2014-207210     Document Type: Article

References (15)

1. Parekh RB, Dwek RA, Sutton BJ, et al. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature 1985;316:452-7.
2. Rombouts Y, Ewing E, van de Stadt LA, et al. Anti-citrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritis. Ann Rheum Dis 2015;74:234-41.
3. Van BK, Coppieters K, Laroy W, et al. Reversible changes in serum immunoglobulin galactosylation during the immune response and treatment of inflammatory autoimmune arthritis. Ann Rheum Dis 2009;68:1360-5.
4. Lauc G, Huffman JE, Pucic M, et al. Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers. PLoS Genet 2013;9:e1003225.
5. Hingorani A, Humphries S. Nature's randomised trials. Lancet 2003;366:1906-8.
6. Okada Y, Wu D, Trynka G, et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 2014;506:376-81.
7. Potter C, Hyrich KL, Tracey A, et al. Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants with tumour necrosis factor response in rheumatoid arthritis. Ann Rheum Dis 2009;68:69-74.
8. Prevoo ML, van 't Hof MA, Kuper HH, et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
9. van Gestel AM, Prevoo ML, van 't Hof MA, et al. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum 1996;39:34-40.
10. Hyrich KL, Watson KD, Silman AJ, et al. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register. Rheumatology (Oxford) 2006;45:1558-65.
11. Symmons DP, Silman AJ. The Norfolk Arthritis Register (NOAR). Clin Exp Rheumatol 2003;21(5 Suppl 31):S94-9.
12. Viatte S, Plant D, Lunt M, et al. Investigation of rheumatoid arthritis genetic susceptibility markers in the early rheumatoid arthritis study further replicates the TRAF1 association with radiological damage. J Rheumatol 2013;40:144-56.
13. Raychaudhuri S, Sandor C, Stahl EA, et al. Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat Genet 2012;44:291-6.
14. Cunninghame Graham DS, Morris DL, Bhangale TR, et al. Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus. PLoS Genet 2011;7:e1002341.
15. Swafford AD, Howson JM, Davison LJ, et al. An allele of IKZF1 (Ikaros) conferring susceptibility to childhood acute lymphoblastic leukemia protects against type 1 diabetes. Diabetes 2011;60:1041-4.